Clinical Trials Arena’s Post

View organization page for Clinical Trials Arena, graphic

3,371 followers

GI INNOVATION and MSD partner for trial of GI-102 and Keytruda regimen for cancer In preclinical studies, GI-102 monotherapy led to complete tumour regression in 60% of mice with liver cancer. - https://lnkd.in/gXE5AVWm #livercancer #clinicaltrials #oncology

GI Innovation and MSD partner for trial of GI-102 and Keytruda regimen for cancer

GI Innovation and MSD partner for trial of GI-102 and Keytruda regimen for cancer

clinicaltrialsarena.com

To view or add a comment, sign in

Explore topics